Advertisement

Topics

Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes

21:44 EDT 27 Jul 2016 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes - AdlyxinTM is approved as Lyxumia® in more than 60 countries - Paris, France - July 28, 2016 - Sanofi announced today that the U.S. Food and Drug...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...